pharma

The EU Clinical Development Roadmap MasterClass - EU edition

02-03 February, 2027

02-03 February, 2027Virtual

MasterClass in Pharma

Translating Clinical Evidence into Regulatory Approval

This masterclass provides a high-level strategic roadmap for navigating the European Union’s clinical regulatory framework. 

 

02-03 February, 2027, Virtual
Time Zone: UTC/GMT+1 /CET 

Key learnings

Understand

Understand EU clinical roadmap and best options for your product submission

Strategic Incentives

Assess Applicability of Strategic Incentives (e.g., ODD, and PIP waivers)

Interpret

Interpret and turn clinical evidence into regulatory approval

Formulate

Formulate High-Level Dossier Defense Strategies.

Trusted by over 17,000 delegates across leading companies

PartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartner

Overview

This masterclass provides a high-level strategic roadmap for navigating the European Union’s clinical regulatory framework. Rather than focusing on hands-on dossier writing, the course equips delegates with a deep conceptual understanding of key EU regulatory tools, when they apply, why to choose specific pathways, and how regulators evaluate evidence. Key topics include evaluating registration pathways, and essential clinical documents to cover, and strategically responding to major regulatory objections.

#masterclass     #glceurope      #pharmaonlinetraining      #globalleadingconferences       #clinical #clinicaldevelopment #clinicalevidence #EUclinical

Explore more

Meet the expert

Trainer

Leena Zino

Leena Zino

Clinical Development Expert

Dr. Leena Zino is a Clinical Development Consultant at DADA, where she leads pharmaceutical safety and efficacy projects and serves as the organization contact for the Middle East region. She holds a Master’s degree in Drug Innovation a Ph.D. in Clinical research where her focus was developing antiretroviral therapies for special patient populations. She is working as a consultant Clinical Development Consultant in multiple companies focusing on clinical trial management, regulatory affairs, and medical writing, including the preparation of clinical and non-clinical overviews and scientific advice applications. She worked with a variety of pharmaceutical products including small-molecules, supplements, and orphan drugs.

Through this masterclass, Dr. Zino helps delegates:
1. Master the European Clinical Roadmap: Gain a structured, high-level understanding of EU approval pathways, regulatory mechanics, and key factors determining market entry success.

2. Evaluate Strategic Regulatory Mechanisms: Understand when and how to leverage key European regulatory tools, including Scientific Advice, Paediatric Investigation Plans (PIPs), and early-access incentives like Orphan Drug Designations (ODD).

3. Navigate Regulatory Scrutiny & Dossier Strategy: Learn how regulators evaluate the benefit-risk balance in clinical data and how to formulate effective response strategies to authority inquiries and source of Major Objections.

Reasons to attend a masterclass

Practical knowledge

Venture into undiscovered territories and gain inspiration through collaboration

Interactivity

Boost your professional skills by directly engaging with domain experts

World-class trainers

Gain value and learn from the best instructors

Networking

Build a top-notch community and advance your career

Recommendation

who should attend image

WHO SHOULD ATTEND

• Regulatory Affairs Managers, Associates and Consultants
• Clinical Trial & Clinical Development associates
• CRO Project Managers and Operations Leads
• Medical Writers & Clinical Regulatory Documentation Specialists
• Small-to-Midsize Biotech Executives & Independent Freelance Consultant

14+

Years of experience

600+

Events organized

4,000+

Speakers

25,000+

Attendees

Take the next step

REQUEST AGENDA FORM